NEW YORK, Dec 21 (Reuters Legal) - A former GlaxoSmithKline Plc lawyer indicted last month for obstructing a U.S. Food and Drug Administration investigation into the company's marketing of antidepressant Wellbutrin was advised by major law firm King & Spalding, according to a document filed in court by her defense team.
No comments:
Post a Comment